| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
EDUCATION EXHIBIT |
1 From the Department of Radiology and Center for Imaging Science (S.C., K.S.L., M.J.C., T.S.K.), Department of Pathology (J.H.), and Department of Medicine (O.J.K.), Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul 135-710, Korea. Presented as an education exhibit at the 2004 RSNA Annual Meeting. Received March 21, 2005; revision requested April 19 and received May 2; accepted May 4. All authors have no financial relationships to disclose. Supported by the SRC/ERC program of MOST/KOSEF (R11-2002-103). Address correspondence to K.S.L. (e-mail: kyungs.lee{at}samsung.com).
Neuroendocrine tumors of the lung arise from Kulchitzky cells of the bronchial mucosa and comprise typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma (LCNEC), and small cell lung cancer (SCLC). At histopathologic analysis, these tumors demonstrate a progressive increase in the number of mitotic figures per 10 high-power fields of viable tumor and in the extent of necrosis, with typical carcinoid having the lowest values and SCLC having the highest. Typical carcinoid is less aggressive than atypical carcinoid, although these tumors have similar gross pathologic and radiologic features; LCNEC has a prognosis between that of atypical carcinoid and that of SCLC. SCLC is the most aggressive pulmonary neuroendocrine tumor and has the most specific imaging feature: mediastinal or hilar lymphadenopathy. At CT, carcinoid tumors appear as a spherical or ovoid nodule or mass with a well-defined and slightly lobulated border. When nonspherical, the tumor is elongated with its long axis parallel to adjacent bronchi. Calcification or ossification is seen in up to 30% of cases. The CT findings of LCNEC are nonspecific and are similar to those of other non–small cell lung cancers. Although there are some overlapping features between these tumors, integration of the clinical and imaging features may be helpful in differentiation of pulmonary neuroendocrine tumors.
© RSNA, 2006
Related Article
RadioGraphics 2006 26: 57-58.
This article has been cited by other articles:
|
|
 |
|
  L. Kamalian, J. R. Gosney, S. S. Forootan, C. S. Foster, Z. Z. Bao, C. Beesley, and Y. Ke Increased Expression of Id Family Proteins in Small Cell Lung Cancer and its Prognostic Significance Clin. Cancer Res., April 15, 2008; 14(8): 2318 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Schuetze, L. H. Baker, R. S. Benjamin, and R. Canetta Selection of Response Criteria for Clinical Trials of Sarcoma Treatment Oncologist, April 1, 2008; 13(suppl_2): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Jeong, K. S. Lee, J. Han, B.-T. Kim, T. S. Kim, Y. M. Shim, and J. Kim Integrated PET/CT of Salivary Gland Type Carcinoma of the Lung in 12 Patients Am. J. Roentgenol., December 1, 2007; 189(6): 1407 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chong, K. S. Lee, B.-T. Kim, J. Y. Choi, C. A Yi, M. J. Chung, D.-K. Oh, and J.-Y. Lee Integrated PET/CT of Pulmonary Neuroendocrine Tumors: Diagnostic and Prognostic Implications Am. J. Roentgenol., May 1, 2007; 188(5): 1223 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Scarsbrook, A. Ganeshan, J. Statham, R. V. Thakker, A. Weaver, D. Talbot, P. Boardman, K. M. Bradley, F. V. Gleeson, and R. R. Phillips Anatomic and Functional Imaging of Metastatic Carcinoid Tumors RadioGraphics, March 1, 2007; 27(2): 455 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Galvin Invited Commentary RadioGraphics, January 1, 2006; 26(1): 57 - 58. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |
